Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase

Oncogene

Volumn 8, Issue 9, 1993, Pages 2425-2432

  Kitagawa, M ^a   Okabe, T ^a   Ogino, H ^a   Matsumoto, H ^a   Suzuki Takahashi, I ^a   Kokubo, T ^a   Higashi, H ^a   Saitoh, S ^a   Taya, Y ^a   Yasuda, H ^a   Ohba, Y ^a   Nishimura, S ^a   Tanaka, N ^a   Okuyama, A ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BUTYROLACTONE; CASEIN KINASE I; CASEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN B; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE H1; LACTONE DERIVATIVE; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLUS; CELL CYCLE; CELL NUCLEUS; COMPETITIVE INHIBITION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

4-BUTYROLACTONE; AMINO ACID SEQUENCE; ASPERGILLUS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; HISTONES; IN VITRO; KINETICS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTAMINE KINASE; PROTEIN KINASE C; PROTEIN KINASES; PROTEIN P34CDC2; RETINOBLASTOMA PROTEIN; SUBSTRATE SPECIFICITY;

ASPERGILLUS;

EID: 0027186226     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)